Investing.com - Edwards Lifesciences (NYSE:EW) reported fourth quarter earnings that missed analysts' expectations on Wednesday and revenue that was inline with forecasts.
The firm reported earnings per share of $0.5 on revenue of $1.19B. Analysts polled by Investing.com forecast EPS of $0.5304 on revenue of $1.19B. .
Edwards Lifesciences shares lost 2.26% to trade at $83.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 6.92%, under-performing the S&P 500 which is down 0.14% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On Tuesday, J&J reported fourth quarter EPS of $1.86 on revenue of $22.48B, compared to forecasts of EPS of $1.83 on revenue of $21.69B.
Novartis ADR earnings missed analyst's expectations on Tuesday, with fourth quarter EPS of $1.34 on revenue of $12.77B. Investing.com analysts expected EPS of $1.36 on revenue of $12.92B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar